Entry Detail



General Information

Database ID:exR0015056
RNA Name:TMSB4X
RNA Type:mRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):12975110End Site(bp):12977227
External Links:ENSG00000205542



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACTB
chr7
5527148
5563784
-
ACTR2
chr2
65227753
65271253
+
AC006064.6
chr12
6556886
6607367
-
ADH5
chr4
99070978
99088801
-
ADPRH
chr3
119579268
119589945
+
ADGRL1
chr19
14147743
14206187
-
AGO2
chr8
140520156
140635633
-
AKT1
chr14
104769349
104795751
-
AC012184.2
chr16
70299194
70372582
+
AC093525.1
chr16
2513965
2527955
+
ADRM1
chr20
62302093
62308862
+
ALDOA
chr16
30064164
30070457
+
AC023055.1
chr12
55757275
55827546
-
AC139530.2
chr17
81703371
81720539
+
AL162417.1
chr9
133098121
133163914
-
AC048338.1
chr12
122207779
122266423
-
AL021546.1
chr12
120438198
120460006
+
AC073508.2
chr17
40627356
40665141
-
ABT1
chr6
26596953
26600739
+
AC073896.1
chr12
56285916
56316059
-
ABHD5
chr3
43690108
43734371
+
AGPAT5
chr8
6708642
6761503
+
ADSL
chr22
40346500
40390463
+
ADORA2A
chr22
24417879
24442357
+
ACAP1
chr17
7336529
7351477
+
AKAP13
chr15
85380571
85749358
+
ACTR1A
chr10
102461881
102502712
-
AFTPH
chr2
64524305
64593005
+
ADD2
chr2
70607618
70768225
-
ACOT7
chr1
6264269
6394391
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-142-3p
chr17
58331245
58331267
-
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-4442
chr3
25664875
25664891
-
hsa-miR-7847-3p
chr11
1880105
1880125
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004554.2
chrX
11668401
11757718
-
AC004687.1
chr17
58330884
58332508
-
AC005618.1
chr5
141326210
141329357
+
AC005899.4
chr17
32328441
32329395
+
AC007744.1
chr2
56147630
56386171
+
AC007780.1
chr17
68413623
68524949
+
AC007952.4
chr17
19112000
19112636
-
AC010247.1
chr19
42132555
42137099
+
AC017104.1
chr2
231388976
231394991
+
AC022167.2
chr16
8848105
8860456
+
AC024940.6
chr12
31280422
31280895
-
AC026362.1
chr12
122975320
122982907
+
AC026461.1
chr16
56682470
56687807
+
AC026471.1
chr16
31456711
31459736
-
AC055854.1
chr8
22690150
22798616
+
AC063949.2
chr12
92421531
92483680
+
AC073896.4
chr12
56162359
56190284
-
AC114271.1
chr19
10333436
10336248
+
AC139149.1
chr17
81514047
81527776
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AJ271736.1
chrX
156004218
156022236
+
AL022311.1
chr22
37876148
37895563
+
AL035458.2
chr20
34234840
34281173
-
AL096870.2
chr14
24209646
24215987
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.